<DOC>
	<DOCNO>NCT02825849</DOCNO>
	<brief_summary>Patients intrauterine adhesion ( Asherman 's Syndrome ) persistent thin endometrial lining vitro fertilization ( IVF ) treatment program , particularly resistant standard therapy , present significant clinical challenge . The aim trial ass intrauterine administration platelet rich plasma ( PRP ) improve endometrial line thickness patient thin line Asherman 's Syndrome .</brief_summary>
	<brief_title>Platelet-rich Plasma ( PRP ) Endometrial Regeneration Repair</brief_title>
	<detailed_description>BACKGROUND : There need new effective therapy patient intrauterine adhesion ( Asherman 's Syndrome ) persistent thin endometrial lining vitro fertilization ( IVF ) treatment program , particularly patient resistant standard therapy HYPOTHESIS : Platelet rich plasma stimulates cellular process involve endometrial regeneration relevant management thin line intrauterine scarring . PRIMARY AIMS : - To measure change endometrial lining thickness SECONDARY AIMS : - To determine fertility improved patient receive platelet rich plasma ( PRP ) : 1 . In patient thin line undergoing frozen embryo transfer ( FET ) , determine : - chance embryo transfer , - implantation rate - clinical pregnancy rate 2 . In patient Asherman 's Syndrome , determine : - rate return/normalization menses - chance spontaneous pregnancy - chance embryo transfer Any adverse effect study arm monitor reported appropriate .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Gynatresia</mesh_term>
	<criteria>Persistent thin line &lt; 6mm &gt; 1 cycle previous IVF FET cycle OR moderatetosevere Asherman 's syndrome Age &lt; 18 year old &gt; 43 year old , Pregnancy , Diagnosis cancer , Hb &lt; 11 g/dL , platelet &lt; 150,000/mm3 , Anticoagulation , NSAIDs 10 day procedure Any significant comorbidity psychiatric disorder would compromise patient safety compliance , interfere consent , study participation , follow , interpretation study result . Incision uterus : myomectomy ; cesarean section</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>43 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>endometrium</keyword>
	<keyword>thin uterine lining</keyword>
	<keyword>uterine scarring</keyword>
</DOC>